Kathleen M Shannon
2PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Feb 20, 2026
The 201 Trial: a placebo-controlled randomized phase 2 study of safety and tolerance of the c-Abl kinase inhibitor risvodetinib in untreated Parkinson's disease.M H Werner, A McGarry, C Meyer
|Jan 15, 2020
Recent Advances in the Treatment of Huntington's Disease: Targeting DNA and RNA.Kathleen M Shannon
Pageof 1
